Taurolidine: Preclinical Evaluation of a Novel, Highly Selective, Agent for Bone Marrow Purging

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703359
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC